Antimalarial activity of cryptolepine and some other anhydronium bases

Phytotherapy Research

Volumn 10, Issue 4, 1996, Pages 361-363

  Wright, C W ^a   Phillipson, J D ^b   Awe, S O ^c   Kirby, G C ^d   Warhurst, D C ^d   Quetin Leclercq, J ^e   Angenot, L ^e  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

alkaloids; Alstonia spp.; cryptolepine; Cryptolepis sanguinolenta; Plasmodium spp.; Strychnos spp.

Indexed keywords

5,6 DIHYDROFLAVOPEREIRINE; ALKALOID; ALSTONINE; CHLOROQUINE; CRYPTOLEPINE; MATADINE; MELINONINE F; NORMELINONINE F; SERPENTINE; STRYCHNOXANTHINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 0029946969     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(199606)10:4<361::AID-PTR845>3.0.CO;2-N     Document Type: Article

References (11)

1. Boye, G. L., and Oku-Ampofo (1983). Clinical uses of Cryptolepis sanguinolenta. In, Proceedings of the First International Seminar on Cryptolepine. 27-30 July 1983, University of Science and Technology, Kumasi, Ghana, p. 37-40.
2. Caprasse, M., Coune, C., and Angenot, L. (1983). Isolement et structure de trois bases anhydronium du Strychnos usambarensis du Rwanda. J. Pharm. Belg. 38, 135-139.
3. Caprasse, M., and Houssier, C. (1984). Physico-chemical investigation of the mode of binding of the alkaloids 5,6-dihydroflavopereirine and sempervirine with DNA. Biochimie 66, 31-41.
4. Coune, C., Tavernier, D., Caprasse, M., and Angenot, L. (1984). La strychnoxanthine, un alcaloide monoterpénique d'un nouveau type isolé à partir du Strychnos gossweileri. Planta Med. 50, 93-95.
5. Ekong, R. M., Kirby, G. C., Patel, G., Warhurst, D. C., and Phillipson, J. D. (1990). Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis. Biochem. Pharm. 40, 297-301.
6. Kirby, G. C., Noamese, B. K., Paine, A., Warhurst, D. C., and Phillipson, J. D. (1995) In vitro and in vivo antimalarial activity of cryptolepine, a plant-derived indoloquinoline. Phytother. Res. 9, 359-363.
7. Kohn, K. W., Waring, M. J., Glaubiger, D., and Friedman, C. A. (1975). Intercalative binding of ellipticine to DNA. Cancer Res. 35, 71-76.
8. Peters, W., Portus, J. H., and Robinson, B. L. (1975). The chemotherapy of rodent malaria XXII. The value of drug resistant strains of Plasmodium berghei in screening for blood schizonticidal activity. Ann. Trop. Med. Parasitol. 69, 155-171.
9. Quetin-Leclercq, J., Coucke, P., Delaude, R., Warin, R., Bassleer, R., and Angenot, L. (1991). Matadine, a cytotoxic alkaloid from Strychnos gossweileri. Phytochemistry 30, 1697-1700.
10. Spath, E., and Lederer, E. (1930). Synthese der Harmalaakaloide: harmalin, harmin und harman. Chem. Ber. 63, 2102-2107.
11. Wright, C. W., Allen, D., Phillipson, J. D. et al. (1993). Alstonia species: are they effective in malaria treatment? J. Ethnopharmacol. 40, 41-45.